Search
for
Sort by
Research 181–210 of 288
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Pathological sequelae of long-haul COVID
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Long-Term Effects of COVID-19
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Organoid technology for tissue engineering
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Disentangling the Coronavirus Disease 2019 Health Disparities in African Americans: Biological, Environmental, and Social Factors
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- COVID-19 infection is a major cause of acute telogen effluvium
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Skin manifestations associated with COVID-19
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- The impact of individual lifestyle and status on the acquisition of COVID-19: A case—Control study
- COVID-19 and hypopituitarism
- A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species